[{"Assets_0_Q1_USD":1007759000.0,"CommonStockSharesOutstanding_0_Q1_shares":57303888.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-95775000.0,"NetIncomeLoss_1_Q1_USD":-96756000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":53209215.0,"StockholdersEquity_0_Q1_USD":886729000.0,"EarningsPerShareBasic_1_Q1_USD":-1.82,"Ticker":"RARE","CIK":"1515673","name":"ULTRAGENYX PHARMACEUTICAL INC.","OfficialName":"Ultragenyx Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5418950849.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]